154 related articles for article (PubMed ID: 8285162)
1. [Results of combination chemotherapy with etoposide, ifosfamide, peplomycin for advanced prostatic cancer].
Ushiyama T; Ihara H; Kurita Y; Kageyama S; Ueda D; Mugiya S; Yamaguchi Y; Nakano M; Suzuki K; Kawabe K
Hinyokika Kiyo; 1993 Dec; 39(12):1139-44. PubMed ID: 8285162
[TBL] [Abstract][Full Text] [Related]
2. [Combination chemotherapy with ifosfamide (or cyclophosphamide), adriamycin, cis-platinum and peplomycin (IAPP) for hormonally resistant metastatic prostatic cancer].
Maeda O; Saiki S; Kinouchi T; Kuroda M; Miki T; Usami M; Kotake T
Hinyokika Kiyo; 1991 Dec; 37(12):1657-62. PubMed ID: 1723841
[TBL] [Abstract][Full Text] [Related]
3. [Combination chemotherapy with ifosfamide, 5-fluorouracil, cisplatin for stage D2 prostatic cancer].
Takeuchi S; Fukui I; Higashi Y; Andoh M; Kihara K; Kitahara S; Horiuchi S; Oshima H
Hinyokika Kiyo; 1989 Sep; 35(9):1513-7. PubMed ID: 2816618
[TBL] [Abstract][Full Text] [Related]
4. [Clinical evaluation of chemohormonal therapy as an initial treatment for stage D2 prostatic cancer--effect of UFT administration combined with hormonal therapy].
Honda M; Takasaki E; Suzuki T; Maeda S; Imai T; Hosoya Y; Chen JA
Gan To Kagaku Ryoho; 1995 Jan; 22(1):105-9. PubMed ID: 7826063
[TBL] [Abstract][Full Text] [Related]
5. [Alternating combination chemotherapy (VIP-DMF) in patients with advanced adenocarcinoma of the prostate].
Yoshimoto J; Ochi J; Tanahashi T; Nanba K; Saegusa M; Hara M; Akagi T; Obama T; Tsushima T; Ozaki Y
Gan To Kagaku Ryoho; 1987 Feb; 14(2):434-9. PubMed ID: 2434029
[TBL] [Abstract][Full Text] [Related]
6. [Treatment of hormonal refractory adenocarcinoma of the prostate with ifosfamide (IFM) and the combination of vincristine ifosfamide and peplomycin (VIP)].
Nukui M; Nakao M; Nakagawa S; Toyoda K; Takada H; Ebisui K; Watanabe H; Miyakoda K; Kobayashi T; Fujiwara M
Hinyokika Kiyo; 1989 Mar; 35(3):415-20. PubMed ID: 2472052
[TBL] [Abstract][Full Text] [Related]
7. [Hormonal treatment of carcinoma of the prostate].
Obata K; Kobayashi H; Murase T; Ohisi M
Hinyokika Kiyo; 1991 Aug; 37(8):809-16. PubMed ID: 1720272
[TBL] [Abstract][Full Text] [Related]
8. [Chemo-endocrine therapy for newly diagnosed stage D2 prostate cancer].
Saito T; Kitamura Y; Komatsubara S
Hinyokika Kiyo; 2005 Dec; 51(12):789-92. PubMed ID: 16440724
[TBL] [Abstract][Full Text] [Related]
9. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
Hagemeister FB
Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
[TBL] [Abstract][Full Text] [Related]
10. [Combination chemotherapy of vincristine, ifosfamide and peplomycin in patients with reactivated prostatic cancer].
Kazama T; Katayama T; Umeda K; Akiya T; Nakada T
Hinyokika Kiyo; 1986 Feb; 32(2):201-5. PubMed ID: 2425607
[TBL] [Abstract][Full Text] [Related]
11. [Combination chemotherapy with 254-S, ifosfamide and peplomycin for advanced or recurrent cervical cancer].
Hirabayashi K; Okada E; Nakazuma Y; Akamatsu Y; Sezaki H; Ohta M; Nakanishi Y
Nihon Sanka Fujinka Gakkai Zasshi; 1992 Mar; 44(3):341-8. PubMed ID: 1376759
[TBL] [Abstract][Full Text] [Related]
12. [Combination therapy with estrogen and UFT in newly diagnosed prostatic cancer (poorly differentiated, stage D2)].
Kondo I; Miura T; Fujii H; Harada M; Fukushima S; Kubota Y; Hosaka M
Hinyokika Kiyo; 1996 Mar; 42(3):201-6. PubMed ID: 8619389
[TBL] [Abstract][Full Text] [Related]
13. [Treatment results of combined hormone and chemotherapy in patients with advanced prostate cancer].
Uekado Y
Hinyokika Kiyo; 1991 Aug; 37(8):825-31. PubMed ID: 1957724
[TBL] [Abstract][Full Text] [Related]
14. [Chemotherapy of prostatic cancer].
Hirao Y; Kubota K; Yoshie T; Tabata S; Samma S; Ozono S; Okajima E; Sasaki K; Yoshikawa M; Tsumatani K
Hinyokika Kiyo; 1991 Aug; 37(8):817-24. PubMed ID: 1720273
[TBL] [Abstract][Full Text] [Related]
15. [Reactivation of prostatic cancer and chemotherapy in reactivated prostatic cancer].
Fuse H; Ando K; Hara S; Zama S; Shimazaki J
Hinyokika Kiyo; 1985 Feb; 31(2):281-7. PubMed ID: 2409787
[TBL] [Abstract][Full Text] [Related]
16. Successful treatment of poor prognostic patients with advanced prostatic carcinoma with the association of diethylstilbestrol and cyclophosphamide.
Germá Lluch JR; Marcuello Gaspar E; de Andrés Basauri L; López Pousa A; López López JJ
Rev Esp Oncol; 1982; 29(2):317-24. PubMed ID: 7188232
[TBL] [Abstract][Full Text] [Related]
17. Ifosfamide/carboplatin/etoposide/paclitaxel in advanced lung cancer: update and preliminary survival analysis.
Strauss GM; Lynch TJ; Elias AD; Jacobs C; Herbst R; Leong T; Lynch C; Kwiatkowski DJ; Carey RW; Grossbard ML; Skarin AT
Semin Oncol; 1997 Aug; 24(4 Suppl 12):S12-73-S12-80. PubMed ID: 9331127
[TBL] [Abstract][Full Text] [Related]
18. Long-term results of first-line sequential high-dose etoposide, ifosfamide, and cisplatin chemotherapy plus autologous stem cell support for patients with advanced metastatic germ cell cancer: an extended phase I/II study of the German Testicular Cancer Study Group.
Schmoll HJ; Kollmannsberger C; Metzner B; Hartmann JT; Schleucher N; Schöffski P; Schleicher J; Rick O; Beyer J; Hossfeld D; Kanz L; Berdel WE; Andreesen R; Bokemeyer C;
J Clin Oncol; 2003 Nov; 21(22):4083-91. PubMed ID: 14568987
[TBL] [Abstract][Full Text] [Related]
19. Anticancer effect of combination therapy of VP16 and fosfesterol in hormone-refractory prostate cancer.
Azuma H; Sakamoto T; Kiyama S; Ubai T; Kotake Y; Inamoto T; Takahara K; Nishimura Y; Segawa N; Katsuoka Y
Am J Clin Oncol; 2008 Apr; 31(2):188-94. PubMed ID: 18391605
[TBL] [Abstract][Full Text] [Related]
20. [Combined hormone and chemotherapy for the patients with advanced prostate cancer].
Uekado Y; Hirano A; Inagaki T; Hiroi A; Watanabe T
Gan To Kagaku Ryoho; 1995 Jul; 22(8):1041-5. PubMed ID: 7611755
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
